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Erythropoiesis is a highly regulated process during
which BFU-E are differentiated into RBCs through
CFU-E,Pro-E,PolyCh-E,OrthoCh-E, and reticulocyte
stages. Uniquely, most erythroid-specific genes are
activated during the Pro-E to Baso-E transition. We
show that a wave of nuclear import of the erythroid-
specific transcription factor EKLF occurs during the
Pro-E to Baso-E transition. We further demonstrate
that this wave results from a series of finely tuned
events, including timed activation of PKCq, phos-
phorylation of EKLF at S68 by P-PKCq(S676), and
sumoylation of EKLF at K74. The latter EKLF modifi-
cations modulate its interactions with a cytoplasmic
ankyrin-repeat-protein FOE and importinb1, respec-
tively. The role of FOE in the control of EKLF nuclear
import is further supported by analysis of the subcel-
lular distribution patterns of EKLF in FOE-knockout
mice. This study reveals the regulatory mechanisms
of the nuclear import of EKLF, which may also be uti-
lized in the nuclear import of other factors.
INTRODUCTION
Erythropoiesis is an orderly proliferation and differentiation
process strictly coordinated by cytokines, growth factors, and
transcription factors from various signal transduction pathways
(Dzierzak and Philipsen, 2013; Koury et al., 2002). Upon the ac-
tion of growth factors, the megakaryocytic/erythroid progenitors
derived from pluripotent hematopoietic stem cells are differenti-
ated into erythropoietin (Epo)-nonresponsive blast-forming unitDevelopmerythrocytes (BFU-E) and Epo-responsive colony-forming units
(CFU-E) (Elliott et al., 2008;Wu et al., 1995). The CFU-Es then un-
dergo several sequential transition steps of differentiation and
finally, via enucleation, yield reticulocytes for development into
mature red blood cells (RBCs) (Hodges et al., 2007).
Among the essential cytokine signaling molecules involved in
erythropoiesis is Epo (Jelkmann, 2007), which functions through
cell surface receptor (EpoR) signaling to activate various
downstream kinase cascades including the protein kinase C
(PKC) pathway in normal erythroid progenitor (ErP) cells (Hedley
et al., 2011; Rivero and Adunyah, 1998). Indeed, PKC theta
(PKCq) is expressed exclusively in the megakaryocytes and
erythroblasts (Oshevski et al., 1999), and PKCq-deficient mice
developed significant lung inflammation (Salek-Ardakani et al.,
2004). Although the activities of distinct PKCq species are known
to be essential for phosphorylation and activation of EpoR and
multiple Epo-induced pathways (Wojchowski et al., 2010), the
specific substrates and/or interacting proteins of the individual
PKCq species in the regulation of proliferation and differentiation
of committed ErPs is largely unknown.
Activation of the kinase cascades during erythropoiesis leads
to activation of a range of erythroid-enriched transcription fac-
tors including GATA-1, FOG-1, TAL-1/SCL, erythroid-specific-
Kruppel-like factor (EKLF), and NF-E2 (Dzierzak and Philipsen,
2013; Kerenyi and Orkin, 2010). Among the genes turned on dur-
ing erythroid maturation, in particular during the transition from
pro-erythroblast (Pro-E) to basophilic erythroblast (Baso-E), are
members of the a-like and b-like globin families (Anguita et al.,
2004; Xu et al., 2010). The function of EKLF is carried out by its
proline-rich transcription activation domain at the N terminus
and three tandem C2H2-type zinc fingers (ZF) at the C terminus
(Miller and Bieker, 1993) that interact with the chromatin remod-
eling complex SWI/SNF (Armstrong et al., 1998). EKLF also ap-
pears to play a role in the spatial organization of the b-like globin
locus in the nucleus (Schoenfelder et al., 2010; Shyu et al.,ental Cell 28, 409–422, February 24, 2014 ª2014 Elsevier Inc. 409
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14.5 (E14.5) due to disruption of bmaj globin expression (Nuez
et al., 1995; Perkins et al., 1995). Further, most of the target
genes of EKLF, as identified in genome-wide analysis, are
involved in terminal erythroid differentiation (Hodge et al.,
2006; Pilon et al., 2011; Tallack et al., 2012). Indeed, EKLF plays
an important role in erythroid differentiation (Yien and Bieker,
2013).
Previously, we have found that in the murine erythroleukemia
(MEL) cells, EKLF is mostly located in the cytoplasm. After
DMSO-induced differentiation, the factor is imported into the nu-
cleus and assembled as discrete dots colocalized with the tran-
scriptionally active b-like globin gene locus, RNA polymerase II,
SC35, and PML protein. In interesting parallel, the majority
of EKLF molecules in most of the late Pro-E, Baso-E, and poly-
chromatic erythroblast (PolyCh-E) stage cells in E14.5 fetal liver
(FL) are also located in the nuclei as discrete dots colocalized
with the b-like globin gene locus (Shyu et al., 2007b). A similar
result has been observed in E13.5 FL cells (Schoenfelder et al.,
2010). These data suggest that in the progenitors and precursor
cells of the erythroid lineage, EKLF is mainly located in the cyto-
plasm. Furthermore, nuclear import of EKLF is necessary for
effective activation of adult b globin gene transcription and that
the colocalization of the b-like globin gene locus with the
EKLF-containing dots/nuclear bodies facilitates this activation
as differentiation proceeds. However, the exact stage(s) at which
the cytoplasmic EKLF is imported into the nucleus and the
mechanisms of this nuclear import process remain uncertain.
In this study, we have identified an EKLF-interacting factor,
which we have termed Foe of EKLF (FOE) for reasons that will
become clear later. FOE is a 1,330 amino acid (aa) long and an-
kyrin repeat (AR) domain-containing protein (NCBI accession
number AF130371). It interacts with and sequesters EKLF in
the cytoplasm thus determining the functional restriction of
EKLF in the ErP cells. By using MEL cells as a model system,
we demonstrate that phosphorylation of EKLF by a transiently
activated form of PKCq and the coupled sumoylation of EKLF
facilitate the nuclear import of EKLF in Pro-E stage cells through
disruption of the EKLF-FOE interaction andmodulation of the as-
sociation-dissociation processes of EKLF with importinb1
(Impb1). We provide a comprehensive model outlining the chain
of reactions that tightly regulate the timed nuclear import of EKLF
during erythropoiesis.
RESULTS
EKLF Translocates into the Nucleus at the CFU-E/Pro-E
to Baso-E Transition
To identify the stage at which EKLF is imported into the nucleus
during erythropoiesis, we investigated the subcellular locations
of EKLF in different types of cells along the erythroid lineage. To
do this, the different types cells of E14.5 FL were isolated by
fluorescence-activated cell sorting (FACS) with the use of anti-
bodies against several hematopoietic lineage markers, CD117,
CD71, and Ter119 (Figure S1A available online). The sorted cells
were analyzed with use of Liu’s stain and brilliant cresyl blue
stain, as described in the Supplemental Experimental Proce-
dures. MEL and DMSO-induced MEL cells were analyzed in
parallel. Consistent with previous reports (Vernimmen et al.,410 Developmental Cell 28, 409–422, February 24, 2014 ª2014 Elsev2007), the majority (87.8%) of the E14.5 FL cells were
of erythroid-lineage, with most (77.8%) being Baso-E and
PolyCh-E (Table S1). Conversely, almost all (98.5%) of the
MEL cells corresponded to the CFU-E/Pro-E type, whereas
most (89.5%) of the DMSO-induced MEL cells were similar to
Baso-E/PolyCh-E (Table S1). Thus, the erythroid maturation
process of MEL cells upon DMSO-induction in vitro indeed cor-
responded to the differentiation from CFU-E/Pro-E to Baso-E/
PolyCh-E in vivo (Figure S1B) (Anguita et al., 2004; Vernimmen
et al., 2007).
The subcellular distribution patterns of EKLF in the different
types of erythroid-lineage cells from the FL were then analyzed
by IF staining in comparison to the MEL cells. First, the sorted
E14.5 FL cells were stained with anti-EKLF, as exemplified in
Figure 1A. Second, we carried out costaining of MEL cells (Fig-
ure 1B) as well as the total E14.5 FL cells (Figure 1C) by using
antibodies against EKLF and P-JNK, the latter of which ap-
peared to be a marker of CFU-E/Pro-E because it was present
in uninduced MEL cells but disappeared upon induction (Lee
et al., 2010). Costaining of the total E14.5 FL cells with use of
anti-P-JNK, anti-CD117, anti-Ter119, and anti-CD71 was also
carried out (Figure S2). Consistent with our previous analysis
(Shyu et al., 2007b; Lee et al., 2010), all of the uninduced MEL
cells analyzed (60/60) contained EKLF and P-JNK, whereas all
of the DMSO-induced MEL cells (48/48) contained only EKLF
but not P-JNK (Figure 1B; Table S2). Conversely, only 9.5% of
the EKLF(+) E14.5 FL cells contained P-JNK, whichwas predom-
inantly located in the cytoplasm. Furthermore, EKLF of these
P-JNK(+) E14.5 FL cells was also predominantly located in
the cytoplasm (Figure 1C; Table S2). We also tabulated and
compared the subcellular distribution patterns of EKLF dots,
smeared EKLF, and P-JNK among MEL cells and the different
type erythroid linage cells of E14.5 FL, as derived from the
data in Figures 1 and S2 and in Table S2. As seen, the import
of the cytoplasmic EKLF into the nucleus during the maturation
of MEL cells was indeed in parallel or similar to that during the
transition of CFU-E/Pro-E to Baso-E in the E14.5 FL.
EKLF Is Sequestered in the Cytoplasm through its
Association with FOE
Interaction of EKLF with FOE and Its Retention in the
Cytoplasm by FOE
In view of the data of Table S2, we hypothesized that some
cytoplasmic factor(s) might interact with and trap EKLF in the
cytoplasm of CFU-E/Pro-E and MEL cells. We used the yeast
2-hybrid (Y2H) system and the ZF/nuclear localization signal
(ZF/NLS2) region of the mouse EKLF(282–376 aa) as the bait to
screen a custom-made MEL cell cDNA library. The ZF/NLS of
EKLF was used as the bait because it interacted with several
different proteins (Siatecka and Bieker, 2011). In this way, we
identified FOE as a EKLF-interacting factor. As depicted in Fig-
ure 2A, FOE consisted of two AR domains, ANK1(87–585 aa)
and ANK2(662–1,021 aa) with 15 and 10 ARs, respectively, at
the N-terminal divided by a Pro-rich region and followed by a
large number of charged residues in the C-terminal. The region
of FOE that interacted with the ZF of EKLF was only comprised
of repeats 2–11 of ANK1 (ANK1-1) (Figures 2A and S3A). This
interaction was specific because ANK2-1 of FOE could not
interact with ZF of EKLF, nor could with other types of ZFs,ier Inc.
Figure 1. Subcellular Distribution of EKLF in
Erythroid Cells along the Erythroid Lineage
(A) IF staining analysis of sorted CFU-E/Pro-E,
Baso-E, PolyCh-E, and OrthoCh-E cells with anti-
EKLF antibody.
(B and C) Subcellular distributions of EKLF and
P-JNK in MEL cells (B) and total E14.5 FL cells (C)
were visualized by IF staining. n, total number of
cells analyzed in each sample.
See also Figures S1 and S2 and Tables S1 and S2.
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interact with ANK1-1 in the Y2H assay (Figure S3A).
At the protein level, FOE was the major species of Ankrd 17
isoforms in MEL cells and E14.5 FL, as shown by immunoblot-
ting (IB) (Figure 2B) by using a lab-made rabbit anti-mouse
FOE antibody specific for FOE (Figure S3B). Interestingly, the
level of FOE protein in MEL cells decreased significantly upon
DMSO induction after 72 hr. However, the change of the levels
of FOE mRNA upon differentiation was not parallel to that of
FOE protein (Figure 2B). This result suggested more degradation
of FOE protein in differentiated or matured erythroid cells. The
exact mechanism(s) by which this occurred was unclear. It might
be due to certain posttranslational modifications (PTMs) of
FOE. Alternately, dissociation of EKLF from FOE during erythroid
differentiation might also make FOE vulnerable to cellular
degradation.Developmental Cell 28, 409–422,To examine whether FOE was able to
interact with EKLF in the mammalian
cells, we performed coimmunoprecipita-
tion (coIP) experiments with extracts
from 293T cells transfected with pFlag-
EKLF and/or pHA-FOE. As a control,
293T cells were also transfected with
pFlag-BKLF that encoded an EKLF-
related ZF protein. The data revealed
that, similar to the result from the Y2H
assay (Figure S3A), FOE also interacted
specifically with EKLF in 293T cells (Fig-
ure 2C, compare lanes 4 and 5).
Whether the endogenous FOE of MEL
cells colocalized with EKLF in the cyto-
plasm was analyzed by visualization of
the subcellular locations of the two pro-
teins by direct labeling of anti-EKLF and
anti-FOE antibodies with fluors Cy3 and
FITC, respectively. Remarkably, similar
to EKLF, FOE also resided mainly as
dots in the cytoplasm of uninduced MEL
cells, and 66% of the cytoplasmic EKLF
dots were colocalized with the FOE dots
(Figure 2D). The interaction between the
endogenous EKLF and FOE in uninduced
MEL cells was also supported by coIP
experiments (Figure 2E) and by IP-mass
spectrometry analysis (Figure S3C). Inter-
estingly, most of the EKLF remaining in
the cytoplasm of DMSO-induced MELcells were still colocalized with the FOE dots, as shown in
Figure 2D.
Release of EKLF into the Nucleus of MEL Cells upon
RNAi Knockdown of FOE
To test the hypothesis that FOE was responsible for seques-
tering EKLF in the cytoplasm of uninduced MEL cells, the cells
were transfected with a FOE siRNA oligo (si) or a scrambled
control RNA oligo (sc), and the subcellular distribution patterns
of EKLF were analyzed by IF microscopy and by IB of
the nuclear/cytoplasmic fractions. As seen, the expression of
FOE in the MEL cells, mostly in the cytoplasm, was knocked
down at 48 hr posttransfection with 50 nM of si oligo (Figure 3A,
compare lanes 1 and 3). This was accompanied by a signifi-
cant nuclear import of EKLF (Figure 3A, compare lanes 2 and
4). Consistent with the IB result, IF staining showed that the
fraction of EKLF located in the nucleus of MEL cells increasedFebruary 24, 2014 ª2014 Elsevier Inc. 411
Figure 2. Colocalization of Cytoplasmic EKLF with FOE
(A) Schematic representation of the domain structure of mouse FOE. The interaction domains between FOE and EKLF, i.e., ANK1-1 of FOE and the ZF of EKLF,
are indicated.
(B) Protein and RNA expression profiles of FOE in MEL cells, DMSO-induced MEL cells, E9.5 bodies and YS, E14.5 YS, and FL, adult spleen and bone marrow
(BM), as assessed by IB with anti-FOE and antitubulin and by RT-qPCR analysis. The data derived from more than three independent experiments were sta-
tistically analyzed by Student’s t test and presented in the histograms below the RT-qPCR panels.
(C) In vivo interaction between EKLF and FOE. CoIP experiments of EKLF and FOE were carried out with extracts from 293T cells transfected with the indicated
plasmids. At 24 hr posttransfection, WCE were prepared and subjected to IP and IB assays using anti-HA and anti-Flag.
(D) Changes in the colocalization pattern of EKLF and FOE in MEL cells upon DMSO-induction. MEL cells with and without DMSO induction for 72 hr were
analyzed by IF staining with anti-EKLF and anti-FOE antibodies. The percentage (%) indicates the average fraction of EKLF dots colocalized with FOE in the
cytoplasm.
(E) Changes of the EKLF-FOE interaction during MEL cell differentiation. WCE from MEL cells with and without DMSO induction for 24 hr and 48 hr were IP with
anti-EKLF and then analyzed by IB using appropriate antibodies. The IB data of EKLF (upper panel) and FOE (lower panel) are shown here. That of P-PKCq(S676)
is shown in Figure S6C. Note the weakness of the FOE signal in the right 2 lanes indicating the dissociation of EKLF from FOE upon MEL differentiation.
See also Figures S3, S4, and S8.
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Figure 3. Sequestering of EKLF in the Cyto-
plasm by FOE
(A) Import of EKLF of MEL cells into the nucleus
upon knockdown of FOE by siRNA. MEL cells
were transfected with scrambled control siRNA
oligonucleotide (sc) or FOE siRNA oligonucleotide
(si) targeting the FOE mRNA, respectively. After
48 hr, the whole-cell extracts (WCE) as well as
the fractionated cytoplasmic (Cy) and nuclear
(Nu) extracts were analyzed by IB using anti-
FOE, anti-EKLF, antitubulin, and anti-HDAC1
antibodies.
(B) The siRNA oligo transfected MEL cells were
analyzed by IF staining with use of anti-EKLF and
anti-FOE antibodies (right panels). For each set,
the percentage (%) indicates the average fraction
per cell of EKLF located in the nucleus.
(C) Subcellular distributions of EKLF in Pro-E cells
of E10.5 YS from the Ankrd17D/Dmice. Pro-E cells
were sorted by FACS and analyzed by IF staining
with use of anti-EKLF and anti-FOE antibodies. n,
total number of cells analyzed. The IB patterns of
the subcellular distributions of FOE and tubulin of
E10.5 YS from the wild-type and Ankrd17D/D mice
are shown on the right.
See also Figures S4 and S8.
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(Figure 3B).
Suppression of EKLF Nuclear Import by Overexpression
of FOE
We also examined the effects of overexpression of FOE in
MEL cells. Several independent clones overexpressing FOE,
MEL(FOE), were generated and isolated (Figure S4A). Signifi-
cantly, the DMSO-induced nuclear import of EKLF in these
MEL(FOE) lines, as exemplified by MEL(FOE)#3, was inhibited
to a much greater extent than the control MEL(V) cells (Fig-
ure S4A), as a result of greater sequestration of EKLF in the cyto-
plasm by the overexpressed FOE. As expected, themRNA levels
of the bmaj and b globin genes in the DMSO-MEL(FOE) cells were
significantly lower than those in DMSO-MEL(V) cells or DMSO-
MEL cells (Figure S4B). The lower level of bmaj globin gene
expression in the DMSO-inducedMEL(FOE) cells was accompa-
nied by a decreased binding of EKLF at the HS2 element and
the bmaj globin promoter, as shown by chromatin immunoprecip-
itation (ChIP) analysis (Figure S4C).
Increased Nuclear Import of EKLF in Pro-E of Ankrd17D/
D Mice
To further explore the role of FOE in the cytoplasmic sequestra-
tion of EKLF in Pro-E and consequently the transition of Pro-E to
Baso-E, we analyzed the proportions of cells at different stages
of the definitive erythroid lineage as well as the subcellular distri-
bution patterns of EKLF in these cells in a line of Ankrd17-defi-
cient mice (Ankrd17D/D) generated using the gene targeting
approach. Because the Ankrd17D/D mice died on E10.5 due to
cardiovascular defects (Hou et al., 2009), blood cells in the blood
vessels of E10.5 yolk sac (YS) or hepatic cord (HC) of the
Ankrd17D/D or wild-type (WT) mice were analyzed. YS and HC
are the two tissues in which definite erythropoiesis occurred atDevelopmE10.5 (Crawford et al., 2010; McGrath et al., 2011). Notably,
although E10.5 YS no longer contained primitive erythroid pro-
genitors (Isern et al., 2011), it contained mature erythroid cells
from the definitive as well as primitive lineages (Dzierzak and Phi-
lipsen, 2013). Interestingly, as shown by Liu’s staining and IF
staining, the percentage of Baso-E was increased from 15% to
53% in the blood of Ankrd17D/D YS and from 17% to 60% in
the blood of Ankrd17D/D HC, respectively, in comparison to the
WT mice (Table 1, upper).
Significantly, the subcellular distribution pattern of EKLF
in Pro-E also changed. As shown in Figure 3C and tabulated
in lower Table 1, unlike Pro-E of E10.5 YS of the WT mice
(19%), the majority of EKLF dots (71%) of Pro-E in blood of
E10.5 Ankrd17D/D YS were located in the nucleus (Table 1,
lower). Together, the data shown in Figures 2, 3, S4, and Table 1
demonstrated that FOE indeed functioned in cell culture as well
as in vivo, as a dock for trapping EKLF in the cytoplasm and
preventing EKLF from entering the nucleus before erythroid
maturation. In particular, EKLF molecules in the FOE-depleted
Pro-E could not be sequestered in the cytoplasm. The conse-
quent import of EKLF into the nucleus then prematurely acti-
vated a set of erythroid-specific as well as ubiquitous genes,
thus shifting the equilibrium of Pro-E/Baso-E transition toward
Baso-E.
PKC Signaling and Sumoylation Facilitate the Nuclear
Import of EKLF
We explored the possible involvement of PTMs and signaling
pathways in the regulation of the nuclear import of EKLF.
By using different protein kinase inhibitors and activators to
treat MEL cells, we found that phorbol 12-myristate 13-acetate
(PMA), the most common activator of PKC, could effectivelyental Cell 28, 409–422, February 24, 2014 ª2014 Elsevier Inc. 413
Table 1. Comparison of the Definitive Erythroid Cell Types and
Subcellular Distribution Patterns of EKLF in Blood Cells in the
Blood Vessels of E10.5 YSorE10.5HCofWTandAnkrd17D/DMice
Definitive Erythroid
Cell Types
Ankrd17+/+ (n = 7) Ankrd17D/D (n = 7)
E10.5 YS cells 552 636
BFU/CFU-E 155 (28%) 79 (12%)
Pro-E 314 (57%) 217 (34%)
Baso-E 83 (15%) 337 (53%)
Poly-E 0 3 (0.5%)
Definitive Erythroid
Cell Types
Ankrd17+/+ (n = 3) Ankrd17D/D (n = 4)
E10.5 HC cells 591 434
BFU/CFU-E 157 (27%) 37 (9%)
Pro-E 332 (56%) 133 (31%)
Baso-E 101 (17%) 258 (60%)
Poly-E 1 (0.2%) 6 (1.4%)
Subcellular Distributions of EKLF Dots in Pro-E and Baso-E
% Ankrd17+/+
Pro-E
Ankrd17D/D
Pro-E
Ankrd17+/+
Baso-E
Ankrd17D/D
Baso-E
EKLF in cytosol 81 29 8 2
EKLF in nucleus 19 71 92 98
Relative proportions of different definitive erythroid cell types, as identi-
fied by their cytology (Frederickson and Harris, 2000; Kingsley et al.,
2013). The definitive erythroid cells were analyzed by Liu’s staining. The
numbers and percentages of different definitive erythroid cells types,
as identified by their morphologies, among the total definitive erythroid
cells populations were calculated and presented. Nondefinitive erythroid
cells or nonerythroid cells were not calculated (upper two tables). The
subcellular distributions of EKLF in Pro-E and Baso-E of the definitive
erythroid cells in the blood vessels of E10.5 yolk sacs from the WT and
Ankrd17D/D mice were analyzed by IF staining (lower table). HC, hepatic
cords; n, number of mice analyzed; WT, wild-type; YS, yolk sac.
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and nuclear translocation of EKLF, as shown by IF staining (Fig-
ure 4A). In addition, we also tested the effect of a posttransla-
tional modifier, SUMO-1, on the nuclear import of EKLF, by
elevating its level in MEL cells. As seen in Figure S5A, the per-
centage of nuclear EKLF in uninduced MEL cells increased
from 24% to 68% and 87%, respectively, upon transfection
with pFlag-DsRed-SUMO-1 or pGFP-SUMO-1. Interestingly,
treatment with the PKC inhibitor (bisindolymaleimide I [BIM])
or the Ser/Thr kinase inhibitor (staurosporine [Stau]) greatly in-
hibited nuclear import of EKLF promoted by the exogenous
SUMO-1 (Figure 4B). Thus, PKC signaling was involved in the
regulation of nuclear import of EKLF and it overrode the effect
of the sumoylation.
PKCq-Mediated Phosphorylation of EKLF at S68
Facilitates theNuclear Import of EKLF byDiminishing Its
Interaction with FOE
Interaction of EKLF with P-PKCq(S676) and Its
Phosphorylation by the Kinase
We analyzed the kinetics of changes in the amounts of different
PKC isoforms and their phospho-forms in MEL cells. In remark-
able contrast to the other PKC isoforms, PKCq was activated by414 Developmental Cell 28, 409–422, February 24, 2014 ª2014 ElsevDMSO, and only one of the active forms of PKCq, P-PKCq(S676),
was detected during the first 24 hr of DMSO induction when
EKLFwas being imported into the nucleus (Figure S5B). It should
be noted here that treatment of MEL cells with FOE siRNA oligo,
which induced nuclear import of EKLF (Figures 3A and 3B), did
not induce phosphorylation of PKCq at S676 (Figure 3A). We
thus hypothesized that P-PKCq(S676) might mediate the nuclear
import of EKLF through its phosphorylation by the kinase.
Whether EKLF physically interacted with P-PKCq(S676) was
first analyzed by IP-IB experiments of the WCE from 293T cells
transfected with pFlag-EKLF. As seen, EKLF interacted specif-
ically with P-PKCq(S676) but not P-PKCq(S695) or the unphos-
phorylated PKCq (Figure 4C). Notably, consistent with the
data of Figure 4, physical interaction between the endogenous
EKLF and P-PKCq(S676) of DMSO-induced MEL cells could
be detected by IP experiment (Figure S5C). The relatively
weak IP signal was likely due to the transient expression of
P-PKCq(S676) and the dynamic nature of the interaction during
MEL cell differentiation.
Significantly, EKLF could be phosphorylated by P-PKCq(S676)
in vitro and very likely in vivo as well. As seen in lane 1 of the
left panels of Figure 4D, a recombinant EKLF fragment rFC-
EKLF(1–120 aa) was labeled with 32P from 32P-ATP after in vitro
phosphorylation reaction in the presence of recombinant
P-PKCq(S676). The same reaction was also carried out with
cold ATP and subjected to mass spectrometry analysis. The
MS/MS and MS3 spectra (Figure 4D, lower panel) demonstrated
that S68 of EKLF was the major site of phosphorylation by the
active P-PKCq. Indeed, mutation of S68 abolished 32P-labeling
of EKLF by the active P-PKCq (Figure 4D, lane 3). Other recombi-
nant rFC-EKLF(121–240 aa) and rFC-EKLF(241–376 aa) could
not be phosphorylated by the recombinant P-PKCq(S676) (Fig-
ure S5D), indicating that S68 was the only phosphorylation site
of EKLF by P-PKCq(S676). In remarkable parallel to the data of
Figures 4C, 4D, and S5B, P-EKLF(S68), similar to P-PKCq(S676),
also appeared transiently at 24 hr post-DMSO induction of the
MEL cells (Figure 4E). These results support the scenario that
P-PKCq(S676) phosphorylated EKLF in vivo transiently during
the early time period of erythroid maturation.
Requirement of an Intact S68 of EKLF for Its Nuclear
Import during Erythroid Maturation
We next tested whether phosphorylation of EKLF at S68 by
P-PKCq(S676) might be required for the nuclear import of
EKLF during erythroid maturation. MEL cells were transfected
with pHA-EKLF and pHA-EKLF(S68A), respectively, and then
treated with DMSO in the presence or absence of PMA. As
seen, S68A mutation drastically reduced the nuclear fraction of
HA-EKLF in DMSO-induced MEL cells from 84% to 19% (Fig-
ure 5A, compare the middle two panels). In an interesting paral-
lel, PMA treatment induced the nuclear import of EKLF (37%),
but not EKLF(S68A) (7%) in MEL cells without DMSO treatment
(Figure 5A, compare the right two panels), although the effect
was not as big as that seen with DMSO induction. Together,
these data demonstrated that phosphorylation of EKLF at S68
by P-PKCq(S676) is essential for the nuclear import of EKLF dur-
ing differentiation of MEL cells.
Release of S68-Phosphorylated EKLF from FOE
We examined whether P-PKCq phosphorylation-induced nu-
clear import of EKLF was mediated in part through an effect onier Inc.
Figure 4. Phosphorylation of S68 of EKLF by
P-PKCq(S676)
(A) PMA stimulation induced EKLF nuclear trans-
location in MEL cells. MEL cells were treated with
160 nM PMA for 0.5 hr and then analyzed by IF
staining with anti-EKLF and anti-P-PKCq.
(B) The effect of PKC inhibitor on SUMO-1 over-
expression-promoted nuclear import of EKLF.
MEL cells were transfected with pFlag-DsRed-
SUMO-1 and then treated with 20 nM Stau or 1 mM
BIM for 0.5 hr at 24 hr posttransfection. The cells
were then costained with anti-EKLF and anti-Flag.
(C) Physical interaction of EKLF with P-PKCq
(S676). MEL cells were transfected with pEF-Flag
and pEF-Flag-EKLF, respectively, and subjected
to IP-IB analysis at 24 hr posttransfection.
(D) In vitro phosphorylation of EKLF by P-PKCq.
The recombinant rFC-EKLF(1–120) or rFC-
EKLF(1–120)(S68A) substrate was incubated with
P-PKCq in the in vitro phosphorylation reaction
mixture, and then analyzed either by autoradiog-
raphy or IB. The phosphorylated rFC-EKLF(1–120)
was also isolated by SDS-PAGEand then analyzed
by mass spectrometry.
(E) Kinetics of changes of the amounts of P-
EKLF(S68), PKCq, and activated PKCq(S676)
during DMSO-induced differentiation of MEL cells.
The cells were harvested and subjected to IB
analysis using the appropriate antibodies.
See also Figures S5 and S8.
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after transfection with pFlag-EKLF and/or pHA-FOE for 24 hr
and then subjected to IP and IB analysis. As expected, PMA
treatment decreased the EKLF-FOE interaction (Figure 5B,
compare lanes 2 and 4), but did not affect the interaction of
EKLF(S68A) with HA-FOE (Figure 5B, compare lanes 6 and 7).
To examine the effect during erythroid differentiation, we trans-
fected MEL cells with pHA-EKLF or pHA-EKLF(S68A) and then
carried out IF microscopy analysis of the transfected cells before
and after DMSO induction. As seen in Figure 5C, in contrast to
the WT HA-EKLF, the S68A mutation prohibited DMSO- and/or
PMA-induced separation of HA-EKLF(S68A) from the endo-
genous cytoplasmic FOE and consequently its nuclear import.
The data in Figures 3 and 4 indicated that PKCq-mediated S68
phosphorylation of EKLF weakened its interaction with FOE,
thus facilitating its release from FOE in the cytoplasm and the
consequent import into the nucleus during erythroid maturation.Developmental Cell 28, 409–422,S68 Phosphorylation-Coupled
Sumoylation at K74 Facilitates the
Nuclear Import of EKLF
Enhancement of EKLF Sumoylation
by PKCq-Mediated S68
Phosphorylation
Reversible PTMs including sumoylation
played important roles in the regulation
of nuclear import of different proteins
(Gasiorowski and Dean, 2003). Further-
more, EKLF could be sumoylated at
Lys74 (Shyu et al., 2007a; Siatecka
et al., 2007). In fact, K74 was the onlysite of EKLF that could be sumoylated in vitro and in transfected
cells (Figures S6A and S6B). Finally, the P-PKCq(S676)-medi-
ated S68 phosphorylation site of EKLF was close to K74, which
was located within a consensus negatively charged amino
acid-dependent sumoylation motif (NDSM) (cKxExx(E/D)4) (Fig-
ure S6C) (Yang et al., 2006). Interestingly, when the status of
EKLF sumoylation in MEL cells during DMSO induction was
followed up by IP-IB experiments, it was found that similar to
P-PKCq(S676) (Figure S5B), the sumoylated EKLF species also
increased 24 hr post-DMSO induction (Figure S5C).
In view of the above, we speculated that S68 phosphorylation
of EKLFmight not only function to dissociate the factor fromFOE,
but it could affect the sumoylation of EKLF, a PTM thatmight also
play a regulatory role in the nuclear import of EKLF during
erythroid maturation. Indeed, as shown in Figure 6A, the acti-
vated PKCq not only phosphorylated EKLF, but it also enhanced
the in vitro sumoylation of EKLF (Figure 6A, compare lanes 3 andFebruary 24, 2014 ª2014 Elsevier Inc. 415
Figure 5. Effect of S68 Phosphorylation of
EKLF by P-PKCq(S676) on EKLF Nuclear
Import
(A) Requirement of intact S68 for DMSO- or PMA-
induced nuclear import of EKLF. MEL cells were
transfected with pHA-EKLF or pHA-EKLF(S68A).
After 24 hr, the cells were treated with 2% DMSO
for 48 hr or with 160 nM PMA for 0.5 hr before
IF staining with anti-HA. Percentage (%) indicates
the average fraction per cell of HA-EKLF or
HA-EKLF (S68A) located in the nucleus. The IB
patterns are shown in the right panels.
(B) Effects of S68A mutation and PMA treatment
on EKLF-FOE interaction. 293T cells were trans-
fected with indicated plasmids and treated with
160 nM PMA for 0.5 hr at 24 hr posttransfection.
At 48 hr posttransfection, theWCEwere prepared,
IP with anti-Flag, and then IB with anti-HA or anti-
Flag.
(C) IF staining analysis of HA-EKLF, HA-EKLF
(S68A), and FOE in transfected MEL cells with or
without DMSO induction and/or treatment with
PMA. The cells were transfected with the appro-
priate plasmid(s) for 24 hr, and then induced with
DMSO for 48 hr with or without prior treatment
with PMA for 0.5 hr. The fixed cells were costained
with anti-HA and anti-FOE.
See also Figure S8.
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observed when the mutant EKLF(S68A) (1–120 aa) was used
as the substrate (Figure S7A). Furthermore, the sumoylation of
EKLF in vitro was enhanced by P-PKCq in a dose-dependent
manner (Figure 6B) while no enhancement of sumoylation
in vitro of other proteins, e.g., UBC9, by the activated PKCq could
be observed (Figure S7B). Interestingly, EKLF sumoylation in vivo
was also enhanced by P-PKCq, as shown by coIP experiments
of extracts from 293T cells coexpressing HA-EKLF or HA-
EKLF(S68A) with Flag-DsRed-SUMO-1 and/or and Myc-UBC9.
As seen in Figure 6C, the Flag-DsRed-SUMO-1 conjugated
HA-EKLF could be detected only when the HA-EKLF,
Flag-DsRed-SUMO-1, and Myc-UBC9 were coexpressed (Fig-416 Developmental Cell 28, 409–422, February 24, 2014 ª2014 Elsevier Inc.ure 6C, lane 6). In contrast to HA-EKLF,
little sumoylation of the mutant HA-
EKLF(S68A)couldbedetected (Figure6C,
lane 3).
Facilitation of Nuclear Import of
EKLF by Sumoylation at K74
The elevation of the cellular levels of
SUMO-1 could induce the nuclear import
of EKLF in MEL cells, as shown in Fig-
ure S5A. To test whether this was due
in part to the sumoylation of EKLF itself,
we cotransfected pHA-EKLF or pHA-
EKLF(K74R) with pFlag-DsRed-SUMO-1
into MEL cells and then analyzed the
subcellular locations of these two exoge-
nously expressed EKLF derivatives by IF
staining. As expected, coexpression of
Flag-DsRed-SUMO-1 forced the nuclearimport of HA-EKLF, but not HA-EKLF(K74R), with a significant
portion (76%) of the HA-EKLF protein detected in the nucleus
and colocalized with the SUMO-1 bodies (Figure S7C).
To examine the effect of K74 mutation on the subcellular
location of EKLF during differentiation, instead of upon
SUMO-1 overexpression, we transfected pHA-EKLF or pFlag-
EKLF(K74R) into MEL cells and then carried out IF staining anal-
ysis before and after DMSO induction. As shown in Figure S7D,
similar to the endogenous EKLF (Figure 1), HA-EKLF mainly
stayed in the cytoplasm of transfected MEL cells and they
were imported into the nucleus upon DMSO induction.
Conversely, the majority of the mutant HA-EKLF(K74R) polypep-
tide stayed in the cytoplasm before as well as after DMSO
Figure 6. Requirement of S68 Phosphoryla-
tion Enhanced K74 Sumoylation of EKLF for
Its Nuclear Import
(A) P-PKCq-mediated phosphorylation and su-
moylation of EKLF in vitro. EKLF was incubated in
the sumoylation reaction mixture with or without
the inclusion of 32P-ATP and P-PKCq. The reaction
products were analyzed by IP and by autoradi-
ography.
(B) P-PKCq dose-dependent enhancement of
EKLF sumoylation in vitro. rFC-EKLF(1–120) was
sumoylated in vitro in the presence of increasing
amounts of P-PKCq (2, 5, 10, and 100 ng, from
left to right). The reaction products were then
analyzed by IB with use of anti-rabbit rFC anti-
body.
(C) Requirement of S68 for efficient sumoylation of
EKLF in vivo. 293T cells were transfected with the
indicated and subjected to IP-IB analysis (upper
two panels).
(D) IF staining analysis of HA-EKLF(K74R) and FOE
in HA-EKLF(K74R)-transfected MEL cells induced
with DMSO and/or treated with PMA. Cells were
transfected for 24 hr, and then inducedwith DMSO
for 48 hr with or without prior treatment with PMA
for 0.5 hr. The fixed cells were then costained with
anti-HA and anti-FOE. The percentages (%) of the
cytoplasmic HA-EKLF(K74R) colocalized with
FOE and the fraction per cell of HA(K74R) located
in the nucleus, respectively, are indicated in the
two rows below each photo.
See also Figures S6, S7, and S8.
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the mutant HA-EKLF(K74R) was still associated with FOE in the
cytoplasm of MEL cells (Figure 6D, left two panels), PMA treat-
ment reduced the amount of FOE-associated HA-EKLF(K74R)
(Figure 6D, right two panels), similar to theWT HA-EKLF in trans-
fected MEL cells (Figure 5C).
The data described above demonstrated that the S68 phos-
phorylation of EKLF is required not only for FOE-trapped EKLF
to dissociate from FOE, but also for efficient sumoylation of
EKLF at K74 and the consequent nuclear import of this factor
during erythroid maturation.
Effects of Phosphorylation and Sumoylation of EKLF on
EKLF-Impb1 Interaction
To further dissect the possible mechanisms of the regulation of
EKLF nuclear import during erythroid maturation, we investi-
gated the effects of phosphorylation and sumoylation of EKLF
on its interaction with Impb1, which interacted with the ZF of
EKLF (Quadrini and Bieker, 2002) andwas known to carry a num-
ber of proteins into the nucleus (Chook and Su¨el, 2011). For this,
we first carried out coIP experiments of extracts from 293T cells
transfected with pFlag-EKLF and/or pHA-FOE. As shown in Fig-
ure 7A, Impb1 indeed interacted with EKLF, but not with FOE. As
expected, the amount of EKLF interacting with Impb1 decreased
in the presence of excess FOE (Figure 7A). It should be noted
here that it was difficult to assay the interaction between the
endogenous EKLF and Impb1 of MEL cells by IP, possibly due
to the relatively low amounts of the two proteins and transient
nature of the interaction.DevelopmTo further understand how the EKLF-Impb1 interaction was
involved in the phosphorylation- and sumoylation-regulated
nuclear import of EKLF, we investigated how PKCq-dependent
phosphorylation and sumoylation of EKLF would affect its
interactions with FOE or Impb1. IP experiments were carried
out with WCE from 293T cells cotransfected with different
expression plasmids and subsequently treated with PMA.
As shown, 0.5 hr of PMA treatment of the transfected 293T
cells enhanced the interaction of Impb1 with EKLF, but not
with EKLF(S68A) (Figure 7B). Thus, in contrast to the negative
effect of PMA on EKLF-FOE binding (Figure 5B), P-PKCq-
mediated phosphorylation of EKLF facilitated its binding with
Impb1.
The effect of sumoylation of EKLF on its interaction with Impb1
was further examined by coexpression of Flag-EKLF or Flag-
EKLF(K74R) with Myc-UBC9 and His-SUMO-1 in 293T cells. A
decrease in the interaction between Flag-EKLF and Impb1 was
observed in the presence of overexpressed Myc-UBC9 and
His-SUMO-1 (Figure 7C, compare lanes 1 and 2). On the other
hand, the interaction between mutant Flag-EKLF(K74R) and
Impb1 was not significantly affected by overexpression of
Myc-UBC9 and His-SUMO-1 (Figure 7C, lanes 3 and 4). Thus,
sumoylation of EKLF at K74 facilitated its dissociation from
Impb1. The data in Figures 4, 5, 6, and 7 together show that
phosphorylation of EKLF at S68 was required not only for the
dissociation of FOE and EKLF, but also enhanced the interaction
of EKLF with Impb1. However, sumoylation of EKLF at K74, as
promoted by the phosphorylation, decreased the interaction of
EKLF with Impb1.ental Cell 28, 409–422, February 24, 2014 ª2014 Elsevier Inc. 417
Figure 7. Physical Interactions among
EKLF, Impb1, and FOE
The data derived from more than three indepen-
dent experiments were statistically analyzed by
Student’s t test and presented in the histograms
below the IB panels.
(A) Interaction between Impb1 and Flag-EKLF. At
24 hr posttransfection of 293T cells with pEF-Flag-
EKLF and pHA-FOE, the WCE were subjected to
IP by anti-Impb1 and IB using anti-HA or anti-Flag.
(B) Effects of S68A mutation and PMA treatment
on the EKLF-Impb1 interaction. CoIP experiments
were carried out with WCE after transfection for
24 hr. The cells were treated with 160 nM PMA for
0.5 hr (lanes 2 and 4). The WCE were IP with anti-
Impb1 and then analyzed by IB with anti-Impb1
and anti-Flag, respectively.
(C) Effects of K74R mutation on EKLF-FOE inter-
action. 293T cells were transfected with one or
more of the indicated plasmids. After transfection
for 24 hr, the WCE were IP with Impb1, and then
analyzed by IB with anti-Flag and anti-Impb1,
respectively.
See also Figure S8.
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During early differentiation of the erythroid lineage, there is a ma-
jor shift in the subcellular location of EKLF from the cytoplasm to
the nucleus. This wave of nuclear import of EKLF is necessary for
a global activation of EKLF-regulated genes and for erythroid
maturation (Shyu et al., 2007b). By analysis of mouse E14.5 FL
cells and MEL cell culture using different approaches including
FACS, Liu’s, and IF staining, we have determined that this major
wave of nuclear import of EKLF occurs during the Pro-E to
Baso-E transition. Using MEL cells as a model system, we
have dissected the regulatory mechanisms of the EKLF nuclear
import process and found that this process consists of sequen-418 Developmental Cell 28, 409–422, February 24, 2014 ª2014 Elsevier Inc.tial associations/dissociations of EKLF
with FOE and Impb1 as regulated by dif-
ferentiation stage-specific phosphoryla-
tion and coupled sumoylation of this
transcription factor (see the model in Fig-
ure S8). Previously, Quadrini et al. (2008)
found that the majority of EKLF resides
in the nucleus of MEL cells before and
after DMSO-induced differentiation. This
inconsistency is difficult to resolve at
this moment due to the different MEL
cell sublines, antibodies, and other
experimental conditions used in the two
studies. Overall, our data suggest that
the switch of the subcellular locations of
EKLF plays an important role in the func-
tioning of this transcription factor as a
regulator of definitive erythropoiesis and
likely the primitive erythropoiesis as well.
EKLF is sequestered in the cytoplasm
of immature erythroid cells including
uninduced MEL cells in culture andBFU-E/CFU-E/Pro-E in vivo (Figure 1; Table S2). This sequestra-
tion is achieved through binding of EKLF with the cytoplasmic
FOE, in MEL cells (Figures 2, 3, S3, and S4), and likely also in
BFU-E/CFU-E/Pro-E (Table 1). Upon extracellular stimuli such
as DMSO and/or Epo, EKLF dissociates from FOE and enters
into the nucleus. The sequestration of proteins in the cytoplasm
by protein-protein interaction is without precedent (Gasiorowski
andDean, 2003). Onewell-known example is the retention of NF-
kB in the cytoplasm, which is achieved through the interaction
between the RHD domain of NF-kB and the AR domain of the
I-kB kinase. This interaction masks the NLS of NF-kB thus pre-
venting its nuclear import (Oeckinghaus and Ghosh, 2009). In
interesting parallel, the FOE-EKLF interaction is through the
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ure 2A). There are two possibilities of how the ZF-NLS of EKLF
is masked through this interaction. First, our preliminary
modeling analysis has suggested that ANK1-1 specifically inter-
acts with two of the three ZF of the ZF-NLS of EKLF (M.-J.H.,
X.C., and C.-K.J.S., unpublished data), thus directly masking
the latter motif and preventing its binding to the importins. Alter-
natively, the FOE interaction with EKLF may induce a conforma-
tional change of EKLF thus masking its NLS. Future structural
analysis will help to differentiate between these two possibilities.
Apparently, the first event in the wave of nuclear import of
EKLF during the Pro-E to Baso-E transition is the transient acti-
vation of PKCq. The activated PKCq, or P-PKCq(S676), physi-
cally interacts with EKLF and phosphorylates it at S68 (Figures
4, 5, 6, and S5C). Regulation of nuclear import by phosphoryla-
tion or dephosphorylation of cargo proteins is well-documented
(Liang and Clarke, 2001; Serfling et al., 2000). Uniquely, the
phosphorylation of EKLF by a single, transiently activated
kinase, PKCq, plays multiple roles in the initiation as well as pro-
gression of the nuclear import of EKLF. First, at the initial step,
phosphorylation of EKLF at S68 by P-PKCq(S676) weakens the
EKLF-FOE interaction thus allowing EKLF to escape from FOE
(Figure 5). The same phosphorylation event also strengthens
the interaction of EKLF with Impb1, thus facilitating its import
through the nuclear pore complex (NPC) (Figure 7B). Because
the EKLF phosphorylation site (S68) is 200 aa away from the
NLS, which is the FOE-interacting as well as Impb1-interacting
domain, both the dissociation of EKLF from FOE and its associ-
ation with Impb1 are likely the result of 3D conformational alter-
ations induced by the phosphorylation at S68.
Next, phosphorylation of EKLF at S68 also promotes the
sumoylation of EKLF. Sumoylation of different cargos them-
selves are important for the regulation of nuclear import process
(Wang and Dasso, 2009). EKLF is sumoylated at K74 (Figures 6,
S5, S6, and S7), a modification necessary for the DMSO- as well
as PMA-induced wave of EKLF nuclear import in MEL cells (Fig-
ures 4 and 6D). Consistent with this, S68Amutation abolishes the
import of EKLF of MEL cells into the nucleus upon DMSO induc-
tion or PMA treatment (Figures 5A and 5C). It should be noted
here that a mutant EKLF(S68D) does not show the phospho-
mimicking functions mentioned above, possibly due to a confor-
mational effect of the S68D mutation (Figure S7A).
For one class of proteins, e.g., HSFs and GATA-1 (Bossis and
Melchior, 2006), phosphorylation-directed sumoylation occurs
at K of the cKxExxSP (PDSMmotif), which has a proline-directed
phosphorylation residue behind the sumoylation site (Gareau
and Lima, 2010). In some other proteins, such as Elk-1 and
PML, the sumoylation sites are located within the NDSM (Fig-
ure S6C) that contains several acidic residues behind the sumoy-
lation sites that are capable of directly interacting with UBC9
(Yang et al., 2006). Thus, the phosphorylation-coupled sumoyla-
tion of EKLF is relatively unique in that, first, the K74 residue of
EKLF is located in a motif like both PDSM and NDSM (Fig-
ure S6C) but its sumoylation is phosphorylation-dependent like
the category of PDSM-containing proteins. Second, in the phos-
phorylation regulated PDSM-containing proteins, the last two
residues of the PDSM are Ser-Pro, however, those of EKLF are
Ser-Gly (Figure S6C). Third, the phosphorylation event regulating
K74 sumoylation of EKLF occurs on S68 located 5 aa to theDevelopmN-terminal side of the PDSM/NDSM-like sequence, instead of
at the canonical S79within thePDSM-like sequence (Figure S6C,
top sequence). It is possible that phosphorylation of S68 induces
a conformational change in EKLF that not only exposes the NLS,
but also releases the acidic NDSM domain thus facilitating the
recruitment of UBC9 for K74 sumoylation. At this moment, we
cannot exclude the likelihood of other SUMO family members,
such as SUMO-2 and SUMO-3, also playing a role in the nuclear
import of EKLF.
Our study has also provided mechanistic insights into the reg-
ulatory role of sumoylation of the cargo proteins in the nuclear
import process. In general, the cargo proteins are sumoylated
at the NPC during their import. It is also known that the NLS is
required to target these proteins to some subnuclear foci, e.g.,
POD, where the sumoylation takes place (Duprez et al., 1999).
In the case of RanGap1, SUMO-1 conjugation facilitates nuclear
import by promoting the interaction between RanGap1 and its
binding protein RanBP2 at the cytoplasmic face of the NPC
(Swaminathan et al., 2004). However, the immediate conse-
quences/effects of the sumoylation reaction in relation to the
facilitation of the nuclear import of many other proteins are
unknown (Wang et al., 2012). Here we show that sumoylation
weakens the interaction of a cargo protein with Impb1 (Fig-
ure 7C). It is likely that EKLF in the EKLF-Impb1 complex gets
sumoylated at the NPC during the import, and the sumoylation
of EKLF at K74 facilitates its separation from Impb1 and conse-
quent release into the nucleus (Figure S8). Similar to the long-
range effect of S68 phosphorylation on the dissociation of
EKLF from FOE, sumoylation of K74 might also induce a
structural alteration of EKLF that weakens its interaction with
Impb1. We suggest that the weakening of the cargo-importin
interaction by sumoylation of the cargos could be a general
mechanism of the nuclear import program for the delivery of
sumoylated proteins into the nucleus.
In conclusion, we have dissected the signaling pathways regu-
lating the nuclear import of EKLF that is critical for the committed
erythroid CFU-E progenitors to enter an irreversible terminal dif-
ferentiation process. Furthermore, because the nuclear import
of EKLF is important for activation/repression of a set of erythroid
genes during the CFU-E/Pro-E to Baso-E transition of the
erythroid lineage, the regulatory mechanisms involved also pro-
vide the basis for further understanding of the dose-dependent
functions of EKLF in the cytoplasm and nucleus of erythroid cells.
In the future, it will be interesting to see whether some of the
revealed regulatory mechanisms of the nuclear import process
are also utilized in the nuclear import of other cargo proteins.
EXPERIMENTAL PROCEDURES
Cell Cultures and Transient DNA Transfection
The cell culturing and DNA transfections were conducted as described previ-
ously (Shyu et al., 2007b). For details, see Supplemental Experimental
Procedures.
Plasmid DNAs and Antibodies
See Supplemental Experimental Procedures for details.
Antibodies
The anti-Impb1, anti-myc, anti-p53, anti-HDAC1, anti-SUMO-1, anti-
P-PKCq(Thr538), and anti-P-PKCq(Ser695) antibodies were purchased fromental Cell 28, 409–422, February 24, 2014 ª2014 Elsevier Inc. 419
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Regulation of the Timed Nuclear Import of EKLFSanta Cruz. The antitubulin, antiactin, and anti-FlagM2mousemonoclonal an-
tibodies were from Sigma. The mouse monoclonal anti-HA antibody was from
Roche. Anti-CD117, anti-CD71, anti-Ter119, anti-CD41, anti-Gr1, and anti-
B220 antibodies were purchased from BD Biosciences. Anti-P-SAPK/
JNK(Thr183/Tyr185) (G9) mouse antibody, anti-SAPK/JNK(56G8) rabbit anti-
body, anti-PKCq rabbit antibody anti-P-PKCq(Ser695), rabbit antibody, and
P-PKC antibody sampler kit were purchased from Cell Signaling Technology.
Anti-EKLF and anti-FOE antibodies were both generated in house. The gen-
eration of the polyclonal rabbit antibody EKLF-1 recognizing mouse EKLF has
been described (Shyu et al., 2006). The antibody was purified from rabbit sera
with use of an affinity column, concentrated, and stored at 20C before use
(see Shyu et al., 2006 for more details). Polyclonal anti-P-EKLF(S68) rabbit
antibody was custom made by LTK BioLaboratories. For generation of anti-
FOE, the C-terminal region of the FOE cDNA (aa 1,033–1,381) was cloned
into pET28a(+) vector (Invitrogen), and the His-tagged fusion protein was pu-
rified using the Ni-NTA column (Novagen) as described by the manufacturer.
The purified protein was used as an antigen for generation of anti-FOE. Affinity
purified anti-FOE was used for immunostaining as well as IB analysis. Anti-
ankrd17 antibody was purchased from Bethyl Laboratories.
Immunofluorescence Staining and Image Analysis
The cells were fixed in 4% formaldehyde for 20 min, permeabilized with
0.1% Triton X-100-PBS, blocked in 10% normal donkey serum (Jackson
ImmunoResearch), and incubated with the appropriate antibodies at 4Cover-
night. Secondary antibodies conjugated to Alexa Fluor 488, Alexa Fluor 568,
or Alexa Fluor 647 (Molecular Probes) were then added, and the incubation
continued for another 2 hr at 25C. Staining of DNA was carried out using
DAPI (40,60diamidino-2-phenylindole; Molecule Probes). MetaMorph software
(Meta Imaging Series, version 6.1, Universal Imaging) was used to quantitate
the relative levels of the signals of immunostaining in the nucleus and cytosol,
respectively.
RT-qPCR and Semiquantitative RT-PCR
The total RNAs were extracted by means of the commercial Trizol reagent
(Invitrogen) and reverse-transcribed using SuperScriptIII according to the
manufacturer’s protocol (Invitrogen). Mouse FOE, bmajor globin, glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH), and actin mRNA levels were
determined by real-time PCR or semiquantitative RT-PCR using appropriate
primers from Mission Biotech: mouse FOE (sense: 50-TCCACCAGATGTCACT
CAGCTAAC-30 and antisense: 50-GTACTGGCTGTCCAACTATCACTCC-30),
bmajor globin (sense: 5
0-GCACCTGACTGATGCTGAGA-30 and antisense: 50-
CCAAGTGATTCAGGCCATC-30), mouse GAPDH (sense: 50-GCTACACTGAG
GACCAGGTTGTC-30 and antisense: 50-GAAGGTGGAAGAGTGGGAGTTG-30)
and mouse actin (sense: 50-CCTCCCTGGAGAAGAGCTATGA-30 and anti-
sense: 50-CCACCGATCCACACAGAGTACTT-30 ). qPCR assays were per-
formed using an Applied Biosystems 7500 Real-Time PCR System (Applied
Biosystems) with the following profile: 1 cycle at 50C for 2 min, 1 cycle at
95C for 10 min, and 40 cycles each at 95C for 15 s and 60C for 1 min.
The threshold cycle (Ct) was calculated by the instrument’s software (7500
System SDS software version 1.3.1). GAPDH served as an internal control,
and the relative amount of FOE mRNA was normalized to GAPDH. Data are
presented as histograms where each bar represents the mean ± SEM of
data derived from three times. Semiquantitative RT-PCR consisted of PCR
incubated at 94C for 5 min, followed by 22 cycles at 94C for 30 s, 55C for
40 s, and 72C for 30 s (actin); 26 cycles at 94C for 30 s, 52C for 30 s, and
72C for 27 s (FOE), and 20 cycles at 94C for 30 s, 52C for 40 s, and 72C
for 20 s (bmajor globin), respectively. Data are presented as histograms where
each bar represents the mean ± SEM of data derived from two times.
In Vitro Sumoylation
The in vitro SUMO-1 conjugation assay was performed as follows. Briefly, 2 mg
of purified His-EKLF or p53 protein was incubated with 7.5 mg/ml of SUMO-1
activating enzyme E1 (SAE1 or SAE2), 50 mg/ml of purified His-SUMO-1, and
50 mg/ml of SUMO-1 conjugating enzyme His-UBC9 in a 20 ml reaction mixture
containing 20 mM HEPES (pH 7.5), 5 mM MgCl2, and 2 mM ATP. After 30 min
at 37C, the reactions were terminated with sodium dodecyl sulfate (SDS)
sample buffer and heated at 100C for 4 min. The reaction products were
analyzed by SDS polyacrylamide gel electrophoresis followed by IB.420 Developmental Cell 28, 409–422, February 24, 2014 ª2014 ElsevIn Vitro Phosphorylation Assay
His-EKLF(1–120) and His-EKLF(1–120)(S68A) were expressed from pQE-
EKLF(1–120) and pQE-EKLF(1–120)(S68A), respectively, in Escherichia coli
strain XL10-gold and purified using a standard procedure. To detect phos-
phorylation by PKCq, 0.5 mg of the purified recombinant proteins were incu-
bated in 20 ml reaction mixture containing 50 ng of the active PKCq (Upstate
Biotechnology) and 4 mCi of [g-32P] ATP in the kinase buffer (Upstate Biotech-
nology). After incubation at 30C for 0.5 hr, the reaction was stopped by 23
SDS sample buffer and boiled for 5 min. The phosphorylated protein products
were separated by 8% SDS-PAGE and analyzed by X-ray autoradiography
and IB (Lee et al., 2010).
Identification of Protein Phosphorylation Sites by Nano-Liquid
Chromatography-Tandem Mass Spectrometry
For details, see Supplemental Experimental Procedures.
siRNA Interference
The target sequences for siRNA oligo targeting the FOE mRNA (50-GAUGUAA
AUGCUGUGCGGAAACUAC-30) and the control scRNA oligo (50-CCUGCUCC
UGAAGAAGAAGTT-30) were from Ambion. MEL cells were transfected with
the duplex RNA oligonucleotides at a concentration of 20 nM or 50 nM after
transfection for 48 hr and analyzed by IB and IF staining.
Immunoblotting and Immunoprecipitation
See Supplemental Experimental Procedures for details (Shyu et al., 2005).
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